Veterinary Medicines Directorate Approves Injectable Formulation of BRAVECTO® (Fluralaner) for Use in Dogs in Great Britain
Milton Keynes, U.K., 24 June, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the Veterinary Medicine Directorate (VMD) has approved BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. This new injectable fluralaner formulation is approved for the immediate and persistent […]